APA (7th ed.) Citation

HR, J., Y, O., D, N., S, M., J, K., D, J., . . . SY, C. (2021). CRISPR screens identify a novel combination treatment targeting BCL-XL and WNT signaling for KRAS/BRAF-mutated colorectal cancers. Oncogene, 40(18), 3287. https://doi.org/10.1038/s41388-021-01777-7

Chicago Style (17th ed.) Citation

HR, Jung, et al. "CRISPR Screens Identify a Novel Combination Treatment Targeting BCL-XL and WNT Signaling for KRAS/BRAF-mutated Colorectal Cancers." Oncogene 40, no. 18 (2021): 3287. https://doi.org/10.1038/s41388-021-01777-7.

MLA (9th ed.) Citation

HR, Jung, et al. "CRISPR Screens Identify a Novel Combination Treatment Targeting BCL-XL and WNT Signaling for KRAS/BRAF-mutated Colorectal Cancers." Oncogene, vol. 40, no. 18, 2021, p. 3287, https://doi.org/10.1038/s41388-021-01777-7.